Market Place
Sourcing Support
Novartis touts more late-stage data for inclisiran
12 Nov 2021 //
ENDPTS
Novartis’ $9.7B PCSK9 drug nabs first OK now comes challenge of finding a market
12 Dec 2020 //
ENDPTS
Novartis completes tender offer for all outstanding shares
08 Jan 2020 //
GLOBE NEWSWIRE
Novartis picks up inclisiran after completion of MedCo acquisition
08 Jan 2020 //
PM LIVE
Novartis completes tender offer for all outstanding shares
07 Jan 2020 //
GLOBE NEWSWIRE
Novartis completes tender offer for all outstanding shares
07 Jan 2020 //
GLOBE NEWSWIRE
Is $9.7B too big a price for The Medicines Company? Novartis itself seems to think so
12 Dec 2019 //
FIERCE PHARMA
Novartis Buys The Medicines Company: A $9.7 Billion Gamble on a PCSK9 Drug
25 Nov 2019 //
BIO SPACE
The Medicines Company Announces ORION-10 Study of Inclisiran in ASCVD Patients
15 Nov 2019 //
BUSINESS WIRE
The Medicines Company to Present Inclisiran Data ORION-9 & ORION-10 Pivotal Ph3
06 Nov 2019 //
BUSINESSWIRE
Medicines Company`s cholesterol buster poised for PCSK9 battle
26 Sep 2019 //
FIERCE BIOTECH
The Medicines Comp`s Inclisiran Treats Cholesterol, No Liver,Renal Side effects
26 Sep 2019 //
BIOSPACE
MedCo builds its case for star cholesterol RNAi therapy
25 Sep 2019 //
ENDPTS
Clean data tee Medicines Company up for PCSK9 scrap
03 Sep 2019 //
FIERCE BIOTECH
Medicines Co.`s cholesterol drug looks good to take on PCSK9 rivals
03 Sep 2019 //
BIOPHARMADIVE
U.S. District Court Invalidates Amgen Patents Over Cholesterol Med
30 Aug 2019 //
BIOSPACE
Praluent, Repatha face major new PCSK9 threat
27 Aug 2019 //
FIERCE PHARMA
Medicines Co.`s PCSK9 drug succeeds in first Phase 3 test
27 Aug 2019 //
BIOPHARMADIVE
Who`s the next Big Pharma takeout target? Biogen, uniQure, AZ top the list
26 Jun 2019 //
FIERCE PHARMA
The Medicines Company Announces Pricing of Public Offering at $33.00 per share
26 Jun 2019 //
BIOSPACE
Med Co, Alnylam`s inclisiran cuts cholesterol long-term
21 May 2019 //
FIERCE BIOTECH
5 Potential Biotech M&A Targets To Watch In 2019
22 Jan 2019 //
SEEKING ALPHA
New CEO Alex Denner shakes up The Medicines Company
11 Dec 2018 //
ENDPTS
Superbugs Win Another Round as Big Pharma Leaves Antibiotics
16 Jul 2018 //
BLOOMBERG
Sanofi, Regeneron to cut price of Praluent
13 Mar 2018 //
FORBES
In The War Against High Drug Prices, Some Patients Are Collateral Damage
12 Mar 2018 //
FORBES
Melinta Completes Acquisition of The Medicines Company’s
08 Jan 2018 //
PRESS RELEASE
Medicines Co. preps for FDA, EMA submissions with +ve top-line pivotal data
27 Jun 2016 //
FIERCE BIOTECH
The Medicines Company appoints Biogen`s Tony Kingsley
25 May 2016 //
PM LIVE
Chiesi nears cardiovascular assets deal with Medicine Co: sources
10 May 2016 //
REUTERS
Pharmalot: China probing drug and device makers for antitrust violations
09 May 2016 //
STAT
Appeals court hears key patent case affecting small drug makers
05 May 2016 //
STAT
New cholesterol methods needed in wake of failed drugs, heart researchers say
05 Apr 2016 //
REUTERS
Mallinckrodt (MNK) Rumored to be Eyeing Sale of Nuclear Imaging Unit
31 Mar 2016 //
BIOSPACE
Mallinckrodt Completes Acquisition Of Commercial-Stage Brands From Medicines Co.
01 Feb 2016 //
PR NEWSWIRE
Drugmaker Medicines Co. Is Said to Explore a Sale
20 Jan 2016 //
BLOOMBERG
The biggest winners--and losers--in the 2015 race for new drug approvals
04 Jan 2016 //
FIERCE BIOTECH
The Medicines Company v. Hospira (Fed. Cir. 2015)
14 Jul 2015 //
PATENT DOCS
Federal Circuit Revokes The Medicines Co.’s Angiomax Patents
13 Jul 2015 //
FDA NEWS
Medicine`s Kengreal (cangrelor) Approved in US For Blood Clots
23 Jun 2015 //
FDA
Medicines` Kengrexal (cangrelor) Approved in Europe For ACS
13 Jun 2015 //
EMA
Medicine`s Orbactiv (Oritavancin) Approved in Europe For Skin Infections
05 May 2015 //
EMA
Medicines` RAPLIXA™ (Fibrin Sealant) Approved in USA For Surgical Bleeding
01 May 2015 //
THE MEDICINES COMPANY
Medecine`s Raplixa Approved in Europe For Surgical Bleeding
28 Apr 2015 //
EMA
After PhIII Odyssey, The FDA Finally Gives Medicines Co. A Thumbs-Up For Cangrelor
14 Apr 2015 //
FIERCE BIOTECH
Sun Pharma settles Angiomax litigation with The Medicines Company
03 Apr 2015 //
THE ECONOMIC TIMES
